Addition of the monoclonal Epidermal Growth Factor (EGF) receptor antibody cetuximab (E) to cisplatin/5-FU (CF) versus CF in 1st line Metastatic Squamous Cell Carcinoma of the esophagus (MESCC): First results of the phase II oesotux trial

Dokumenttyp:: Meeting Abstract
Autor(en):: Lorenzen, S; Porschen, R; Al-Batran, SE; Hofheinz, R; Thuss-Patience, P; Möhler, M; Grabowski, P; Arnold, D; Greten, T; Müller, L; Gerecke, U; Rothling, N; Schuster, T; Peschel, C; Lordick, F
Titel:: Addition of the monoclonal Epidermal Growth Factor (EGF) receptor antibody cetuximab (E) to cisplatin/5-FU (CF) versus CF in 1st line Metastatic Squamous Cell Carcinoma of the esophagus (MESCC): First results of the phase II oesotux trial
Zeitschriftentitel:: Onkologie
Jahr:: 2008
Band / Volume:: 31 Suppl.
Seitenangaben Beitrag:: 91-91
Sprache:: eng
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/18322411
Print-ISSN:: 0378-584X
TUM Einrichtung:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Vorkommen: